Victoria P Werth MD

Dermatopathology

Professor of Dermatology, University Pennsylvania

3400 Spruce Street2 Rhoads PavilionPhiladelphia, PA 19104
Phone+1 215-662-2737
Fax+1 215-349-8339

Dr. Werth is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Werth's full profile Already have an account?

Education & Training

NYU Grossman School of MedicineResidency, Dermatology, 1983 - 1986
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1980 - 1983
Johns Hopkins University School of MedicineClass of 1980

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

PA State Medical License 1989 - 2026
IL State Medical License 1982 - 1984
MD State Medical License 1980 - 1983
American Board of Dermatology Dermatology
American Board of Dermatology Dermatological Immunology/Diagnostic & Laboratory Immunology
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013, 2015-2017
CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013, 2015-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017

Clinical Trials

Use of Infliximab for the Treatment of Pemphigus Vulgaris
COMPLETED
PHASE2
Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris
TERMINATED
PHASE2
Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser
COMPLETED
PHASE2

Publications & Presentations

PubMed

Litifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC study.
Victoria P Werth, Joseph F Merola, Richard Furie, Kenneth Kalunian, Ronald F van Vollenhoven
Journal of the European Academy of Dermatology and Venereology. 2026-09-01
International development of Investigator Global Assessment scores for pemphigus.
Dédée F Murrell, Darby Boucher, Maryam Daneshpazhooh, Hamidreza Mahmoudi, Nika Kianfar
Journal of the European Academy of Dermatology and Venereology. 2026-09-01
Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.
Didem Saygin, Matthew Diller, Varsha Surampudi, Mark Bodkin, Payam Noroozi Farhadi
Arthritis Care & Research. 2026-09-01

Journal Articles

Creation and Validation of Classification Criteria for Discoid Lupus Erythematosus
Scott A Elman, Hee Joo Kim, Victoria P Werth, JAMA Dermatology
Fatigue in Systemic Lupus Erythematosus and Other Autoimmune Skin Diseases
V P Werth, D Pearson, C J Kushner, The British Journal of Dermatology
Systemic Sclerosis: Current Concepts of Skin and Systemic Manifestations
David R Pearson, Victoria P Werth, ScienceDirect

Lectures

Recent Advances in Bullous Diseases
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019

Authored Content

Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusJune 2020
Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusJune 2020
Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusJune 2020

Press Mentions

Coming Therapies for Cutaneous Lupus Relevant for DermatologistsDecember 3rd, 2025
Treatment Pipeline for Cutaneous Lupus May ‘Offer Hope Very Soon’July 18th, 2025
Phase 2 Trial Supports TYK2 Inhibitor for Cutaneous Lupus, Paving Way for Pivotal TrialsApril 1st, 2025

Grant Support

Extracellular vesicles as a novel mediator for ultraviolet-B light induced photoaging and skin inflammation.PHILADELPHIA VA MEDICAL CENTER2023–2027
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus.ZYLO THERAPEUTICS, INC.2023–2025
A nonpsychoactive cannabinoid receptor-2 agonist to treat itch and inflammation in dermatomyositisUNIVERSITY OF PENNSYLVANIA2020–2025